| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735059 | Transfusion and Apheresis Science | 2018 | 6 Pages |
Abstract
In conclusion, there were significant reductions in large and intermediate size LDL particles during apheresis, and a non-significant reduction in small LDL particles. There were only non-significant reductions in the LDL subclasses during evolocumab treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Knut Tore Lappegård, Christian Abendstein Kjellmo, Stefan Ljunggren, Karin Cederbrant, Maritha Marcusson-Ståhl, Monica Mathisen, Helen Karlsson, Anders Hovland,